Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Rev. Q YoY | Rev. growth | Rev. 3Y | Rev. 5Y | EPS Q YoY | EPS growth | EPS 3Y | EPS 5Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | +50.1% | +39.5% | 13.6% | 28.8% | +156% | +124% | 46.7% | 5.2% | |
| 2 | $406.97 | −0.96% | $365B | +0.37% | +6.5% | 11.4% | 11.7% | +61.5% | −32.7% | −14.5% | −3.8% | |
| 3 | $250.43 | −4.1% | $256B | +25.8% | +24.3% | 29.0% | 40.6% | – | – | – | – | |
| 4 | $306.08 | −7.3% | $108B | +35.1% | +32.0% | 31.4% | 51.2% | – | – | – | – | |
| 5 | $840.70 | −8.6% | $75.4B | +109% | +83.2% | 19.5% | 11.6% | – | – | – | – | |
| 6 | $52.15 | +1.9% | $57.4B | +73.1% | +14.6% | −3.6% | 28.9% | +44.0% | −5.6% | −23.0% | – | |
| 7 | $258.70 | −10.9% | $44.9B | +104% | +98.5% | 120% | – | +186% | – | – | – | |
| 8 | $274.37 | −7.4% | $42.9B | +69.8% | +74.9% | 0.37% | 0.44% | +189% | +217% | −6.3% | −4.1% | |
| 9 | $32.12 | +0.38% | $42.2B | +11.6% | +11.5% | – | – | – | – | – | – | |
| 10 | $191.31 | +0.55% | $41.0B | – | – | – | – | – | – | – | – | |
| 11 | $83.63 | −0.82% | $34.3B | +11.2% | +3.4% | – | – | +23.0% | −11.3% | – | – | |
| 12 | $54.73 | −7.4% | $32.7B | +62.0% | +52.5% | 41.8% | 76.5% | – | – | – | – | |
| 13 | $54.87 | −9.7% | $30.3B | +112% | +115% | – | – | – | – | – | – | |
| 14 | $36.91 | −1.6% | $26.7B | −33.5% | −67.6% | −36.0% | −19.1% | – | – | – | – | |
| 15 | $124.15 | −7.1% | $25.7B | +37.9% | +42.4% | 29.9% | – | – | – | – | – | |
| 16 | $73.47 | −1.8% | $24.8B | +33.0% | +32.2% | 39.0% | 37.4% | +2618% | +3587% | – | – | |
| 17 | $91.73 | −29.2% | $17.6B | +61.1% | +66.6% | 48.9% | – | +178% | – | – | – | |
| 18 | $343.12 | −1.6% | $16.4B | +18.6% | +60.8% | −5.8% | −10.4% | −233% | – | – | – | |
| 19 | $94.39 | −4.5% | $11.6B | +28.7% | +26.4% | 23.8% | 28.7% | – | – | – | – | |
| 20 | $21.65 | −3.0% | $11.5B | +48.2% | +43.4% | – | – | – | −947% | – | – | |
| 21 | $11.04 | −3.0% | $11.5B | +70.3% | +408% | 434% | 178% | – | – | – | – | |
| 22 | $57.50 | +1.2% | $11.2B | +3.2% | – | 0.97% | 5.9% | −13.7% | – | – | – | |
| 23 | $83.53 | −0.64% | $10.8B | −3.5% | +7.7% | 22.5% | 16.3% | −277% | – | – | – | |
| 24 | $77.02 | −1.2% | $10.6B | −1.2% | +1.3% | 22.0% | 19.3% | – | – | – | – | |
| 25 | $24.30 | −7.2% | $9.9B | +29.2% | +30.4% | – | – | – | – | – | – | |
| 26 | $332.29 | +2.4% | $9.8B | +24.1% | +22.6% | – | – | +38.8% | +62.2% | – | – | |
| 27 | $110.19 | −1.1% | $9.6B | +10.3% | +7.4% | 6.0% | 8.9% | +151% | +64.2% | −0.21% | 23.6% | |
| 28 | $56.15 | −4.8% | $9.4B | +16.9% | +17.1% | −0.39% | 4.2% | +79.2% | +45.1% | −17.9% | −7.4% | |
| 29 | $30.37 | −1.4% | $9.4B | +70.4% | +42.8% | 43.5% | 90.8% | – | – | – | – | |
| 30 | $61.18 | +5.3% | $9.4B | +70.3% | +76.1% | 505% | 427% | −70.6% | +641% | – | – | |
| 31 | $35.92 | +0.17% | $8.6B | +15.2% | +13.8% | – | – | +14.6% | +25.9% | – | – | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | – | – | – | – | – | – | – | – |
| 33 | $53.76 | −0.83% | $8.3B | +19.0% | +20.8% | 15.4% | 2.3% | −1.2% | +37.1% | 28.1% | −0.12% | |
| 34 | $28.52 | 0.00% | $8.3B | +45.4% | – | – | – | – | – | – | – | |
| 35 | $76.29 | −1.9% | $8.3B | +94.5% | +141% | 45.5% | −35.7% | +14.0% | +16.7% | −3.5% | 11.6% | |
| 36 | $41.00 | −1.3% | $7.9B | +7.7% | +6.5% | 6.2% | 7.0% | −3.7% | −3.3% | 3.1% | 11.2% | |
| 37 | $25.81 | −9.0% | $7.9B | +94.3% | +88.5% | – | – | – | – | – | – | |
| 38 | $23.38 | −1.7% | $7.7B | +4.6% | +12.6% | 13.5% | – | +45.0% | +137% | – | – | |
| 39 | $110.90 | −3.4% | $7.7B | +7.5% | +5.5% | 0.63% | 5.5% | −63.4% | −16.1% | −9.1% | 2.0% | |
| 40 | $47.81 | −3.8% | $7.6B | +9.1% | +15.2% | 29.7% | – | +51.6% | +113% | 1.4% | – | |
| 41 | $65.55 | +1.0% | $7.4B | +23.7% | +14.6% | – | – | – | – | – | – | |
| 42 | $59.40 | −10.6% | $7.3B | +81.4% | – | – | – | −208% | – | – | – | |
| 43 | $18.34 | −1.1% | $7.2B | −2.3% | +4.3% | −1.4% | 3.3% | +25.0% | +13.6% | 3.1% | 1429% | |
| 44 | $24.34 | +0.12% | $6.9B | −0.03% | +1.3% | 5.7% | 5.2% | – | – | – | – | |
| 45 | $165.13 | −3.8% | $6.8B | +11.4% | +15.5% | 14.7% | 10.3% | −3.8% | −12.8% | – | – | |
| 46 | $26.10 | −2.0% | $6.8B | +35.4% | +34.8% | – | – | – | – | – | – | |
| 47 | $322.75 | +1.7% | $6.4B | −31.8% | +1.0% | 11.0% | 10.4% | −125% | +18.7% | – | – | |
| 48 | $96.87 | +0.23% | $6.4B | – | – | – | – | – | – | – | – | |
| 49 | $51.31 | +3.3% | $6.3B | +3.0% | +4.9% | 4.4% | 8.4% | +4.5% | +28.9% | 17.3% | – | |
| 50 | $16.00 | −11.7% | $6.3B | −1.2% | +24.7% | – | – | −213% | −192% | – | – |